...
首页> 外文期刊>Carcinogenesis >MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5
【24h】

MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK/STAT3 signaling pathway by targeting SOCS5

机译:MicroRNA-301A通过瞄准SOCS5通过JAK / Stat3信号传导途径促进胰腺癌入侵和转移

获取原文
获取原文并翻译 | 示例

摘要

Pancreatic cancer is one of the most lethal digestive malignant tumors. We had previously found that microRNA-301a (miR-301a) is a oncogenic microRNA whose recognized conduce to nuclear factor-kappa B (NF-kappa B) activation in pancreatic cancer, yet the underlying mechanisms of miR-301a in promoting pancreatic cancer invasion and migration is obscure. In this work we found that high expression of miR-301a in human pancreatic cancer patients is related to poor survival. Overexpression of miR-301a enhances pancreatic cancer cell invasion, angiogenesis and migration, whereas inhibition of miR-301a suppresses pancreatic cancer cell invasion and reduces orthotopic pancreatic tumor growth and metastasis. Furthermore, suppressor of cytokine signaling 5 (SOCS5) is identified as a target gene of miR-301a. We found that miR-301a suppressed the expression of SOCS5 leads to janus kinase/signal transducer and activator of transcription 3 (JAK/STAT3) activation and is related to poor overall survival of pancreatic cancer patients. Taken together, our data show for the first time that the feedback loop between miR-301a and JAK/STAT3 pathway may play a significant role in pancreatic cancer invasion and metastasis. Targeting the loop may prove beneficial to prevent metastasis and provide a more effective therapeutic strategy for pancreatic cancer.
机译:胰腺癌是最致命的消化恶性肿瘤之一。我们以前发现MicroRNA-301a(miR-301a)是一种致癌细微荷兰,其认可的microRNA,其认可融资于胰腺癌中的核因子-kappa b(nf-κB)活化,但MiR-301a在促进胰腺癌入侵方面的潜在机制和迁移是模糊的。在这项工作中,我们发现人类胰腺癌患者MiR-301a的高表达与存活率不佳有关。 miR-301a的过度表达增强了胰腺癌细胞侵袭,血管生成和迁移,而MiR-301a的抑制抑制了胰腺癌细胞侵袭并降低了原位胰腺肿瘤生长和转移。此外,细胞因子信号传导5(SOCS5)的抑制因miR-301a的靶基因。我们发现miR-301a抑制了SOCS5的表达,导致Janus激酶/信号传感器和转录3(JAK / STAT3)激活的激活剂与胰腺癌患者的整体存活率有关。我们的数据显示,我们的数据显示第一次MiR-301a和Jak / Stat3途径之间的反馈环路可能在胰腺癌侵袭和转移中发挥重要作用。靶向循环可能证明是有益的,以防止转移,并为胰腺癌提供更有效的治疗策略。

著录项

  • 来源
    《Carcinogenesis 》 |2020年第4期| 共13页
  • 作者单位

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Pathol Wuhan 430014 Peoples R;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Canc Res Inst Wuhan Wuhan 430014;

    Huazhong Univ Sci &

    Technol Cent Hosp Wuhan Tongji Med Coll Dept Med Lab Wuhan 430014 Peoples;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号